ZA988794B - Nicotine compositions and methods of formulation thereof - Google Patents
Nicotine compositions and methods of formulation thereofInfo
- Publication number
- ZA988794B ZA988794B ZA988794A ZA988794A ZA988794B ZA 988794 B ZA988794 B ZA 988794B ZA 988794 A ZA988794 A ZA 988794A ZA 988794 A ZA988794 A ZA 988794A ZA 988794 B ZA988794 B ZA 988794B
- Authority
- ZA
- South Africa
- Prior art keywords
- offspring
- precursors
- liquid crystals
- dispersions
- nicotine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Dispersion Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9703458A SE9703458D0 (sv) | 1997-09-25 | 1997-09-25 | Nicotine compositions and methods of formulation thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA988794B true ZA988794B (en) | 1999-04-01 |
Family
ID=20408364
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA988794A ZA988794B (en) | 1997-09-25 | 1998-09-25 | Nicotine compositions and methods of formulation thereof |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1023069B1 (hu) |
JP (1) | JP2001517624A (hu) |
KR (1) | KR20010024305A (hu) |
CN (1) | CN1123343C (hu) |
AT (1) | ATE253362T1 (hu) |
AU (1) | AU733619B2 (hu) |
BR (1) | BR9815395A (hu) |
CA (1) | CA2304042A1 (hu) |
DE (1) | DE69819548T2 (hu) |
DK (1) | DK1023069T3 (hu) |
EE (1) | EE200000154A (hu) |
ES (1) | ES2210817T3 (hu) |
FI (1) | FI20000692A (hu) |
HU (1) | HUP0004802A3 (hu) |
MX (1) | MXPA00002955A (hu) |
NO (1) | NO20001540L (hu) |
NZ (1) | NZ503408A (hu) |
PT (1) | PT1023069E (hu) |
RU (1) | RU2201747C2 (hu) |
SE (1) | SE9703458D0 (hu) |
WO (1) | WO1999015171A1 (hu) |
ZA (1) | ZA988794B (hu) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6638621B2 (en) * | 2000-08-16 | 2003-10-28 | Lyotropic Therapeutics, Inc. | Coated particles, methods of making and using |
US8256433B2 (en) | 1999-07-16 | 2012-09-04 | Aradigm Corporation | Systems and methods for effecting cessation of tobacco use |
US6799576B2 (en) | 1999-07-16 | 2004-10-05 | Aradigm Corporation | System for effecting smoking cessation |
AT409219B (de) * | 1999-08-13 | 2002-06-25 | Red Bull Gmbh | Verwendung von nikotin zum herstellen von arzneimitteln |
KR100381622B1 (ko) * | 2000-08-30 | 2003-04-26 | 디디에스텍주식회사 | 자극성을 줄인 염기성 약물의 구강 투여 조성물 |
DE10057769A1 (de) * | 2000-11-22 | 2002-05-23 | Beiersdorf Ag | Haarpflegeprodukte mit einem Gehalt an dispersen Flüssigkristallen, welche kubische Phasen darstellen |
SE521512C2 (sv) | 2001-06-25 | 2003-11-11 | Niconovum Ab | Anordning för administrering av en substans till främre delen av en individs munhåla |
AU2003209750A1 (en) * | 2002-03-30 | 2003-10-13 | Gunther Beisel | Preparation containing fatty acid, used for reducing appetite, satiating, and/or reducing weight |
US20040002520A1 (en) * | 2002-07-01 | 2004-01-01 | Soderlund Patrick L. | Composition and method for cessation of Nicotine cravings |
KR100443722B1 (ko) * | 2002-09-26 | 2004-08-09 | 이용원 | 니코틴을 함유한 하드츄잉캔디 및 그의 제조방법 |
DE60313216T2 (de) | 2002-12-20 | 2008-01-03 | Niconovum Ab | Chemisch und physikalisch stabiles teilchenförmiges material enthaltend nikotin und microcrystalline cellulose |
FR2851470B1 (fr) * | 2003-02-20 | 2007-11-16 | Besins Int Belgique | Composition pharmaceutique pour administration transdermique ou transmuqueuse |
US9358296B2 (en) | 2003-02-24 | 2016-06-07 | Pharmaceutical Productions Inc. | Transmucosal drug delivery system |
US9254294B2 (en) | 2003-02-24 | 2016-02-09 | Pharmaceutical Productions Inc. | Transmucosal hormone delivery system |
US10172810B2 (en) | 2003-02-24 | 2019-01-08 | Pharmaceutical Productions, Inc. | Transmucosal ketamine delivery composition |
US9498454B2 (en) * | 2003-02-24 | 2016-11-22 | Pharmaceutical Productions Inc. | Transmucosal drug delivery system |
US8992974B2 (en) * | 2003-02-24 | 2015-03-31 | Pharmaceuticals Productions, Inc. | Transmucosal drug delivery system |
GB0322033D0 (en) * | 2003-09-19 | 2003-10-22 | Camurus Ab | Composition |
US8627828B2 (en) | 2003-11-07 | 2014-01-14 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
CN104397869B (zh) | 2003-11-07 | 2016-06-08 | 美国无烟烟草有限责任公司 | 烟草组合物 |
US7125954B2 (en) | 2005-01-27 | 2006-10-24 | General Electric Company | Method for producing polyether polymers |
US20080219935A1 (en) * | 2005-07-08 | 2008-09-11 | Sang-Hoon Kwak | Phase Transitive Breath Care Products |
JP5694645B2 (ja) | 2006-03-16 | 2015-04-01 | ニコノヴァム エービーNiconovum Ab | 改善された嗅ぎたばこ組成物 |
WO2007118653A2 (de) * | 2006-04-11 | 2007-10-25 | Koko Kosmetikvertrieb Gmbh & Co. Kg | Nanopartikel, enthaltend nicotin und/oder cotinin, dispersionen und die verwendung derselben |
US20080287507A1 (en) * | 2007-05-16 | 2008-11-20 | John Hedenstrom | Nicotine containing toiletry waters |
GB2469792A (en) * | 2009-04-23 | 2010-11-03 | Calvin John Ross | Oil-based pharmaceutical formulation for sublingual delivery |
GB2476471A (en) * | 2009-12-22 | 2011-06-29 | Norwich Pharma Technologies Ltd | Cotinine formulation for the treatment of obesity |
US8846725B2 (en) * | 2011-01-24 | 2014-09-30 | Quadex Pharmaceuticals, Llc | Highly penetrating compositions and methods for treating pathogen-induced disordered tissues |
CN102552405B (zh) * | 2012-03-21 | 2013-10-16 | 张伟 | 一种肛周术后麻醉镇痛的药物组合物的制备方法 |
CN103040741B (zh) * | 2012-12-11 | 2014-11-05 | 中山大学 | 溶致液晶的前体混悬液及其制备方法 |
US20160015703A1 (en) * | 2013-03-07 | 2016-01-21 | Danmarks Tekniske Universitet | Nano- microdelivery systems for oromucosal delivery of an active ingredient |
KR20230013165A (ko) * | 2013-05-06 | 2023-01-26 | 쥴 랩스, 인크. | 에어로졸 장치를 위한 니코틴 염 제제 및 그 방법 |
WO2015090337A1 (en) * | 2013-12-20 | 2015-06-25 | Fertin Pharma A/S | Nicotine powder composition |
CN105828819A (zh) * | 2014-04-08 | 2016-08-03 | 桑萨(巴巴多斯)公司 | 烟碱制剂及其制备方法 |
GB201414919D0 (en) * | 2014-08-21 | 2014-10-08 | Corbitt Terence Simon | Formulations for transmucosal delivery |
CN108323791B (zh) * | 2018-01-03 | 2021-02-12 | 云南中烟工业有限责任公司 | 一种尼古丁-氧化锌复合物、其制备方法及包含其的烟草制品 |
CA3096580C (en) * | 2018-04-16 | 2023-05-23 | Poviva Corp. | Compositions infused with nicotine compounds and methods of use thereof |
CN109125251B (zh) * | 2018-09-10 | 2021-08-13 | 武汉百纳礼康生物制药有限公司 | 一种包载蛋白类药物的温敏性液晶凝胶制剂及其制备方法 |
KR102186704B1 (ko) | 2019-02-18 | 2020-12-04 | (주)아이엠디팜 | 서방성 지질 전구 제제 및 이를 포함하는 지질 용액 형태의 서방성 주사용 약학 조성물 |
LU101511B1 (en) * | 2019-12-02 | 2021-06-04 | Herrera Arturo Solis | (S)-3-[1-Methylpyrrolidin-2-yl]pyridine, analogues thereof, precursors thereof, or its derivatives, for the use as a pharmaceutical in form of a parenteral administration and a process for the preparation of an injectable substance |
LU101520B1 (en) * | 2019-12-02 | 2021-06-07 | Herrera Arturo Solis | (S)-3-[1-Methylpyrrolidin-2-yl]pyridine, analogues thereof, precursors thereof, or its derivatives, for the use as a pharmaceutical in form of a homogeneous, viscous, semi-solid topical medication and topical medication |
NL2031331B1 (en) | 2022-03-18 | 2023-09-29 | Plethora Therapeutics B V | Transmucosal delivery of a short-acting psychedelic compound |
NL2031332B1 (en) | 2022-03-18 | 2023-09-29 | Plethora Therapeutics B V | Transmucosal delivery of psychoactive compounds |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5371109A (en) * | 1986-07-01 | 1994-12-06 | Drilletten Ab | Controlled release composition for a biologically active material dissolved or dispersed in an L2-phase |
IL86170A (en) * | 1987-05-01 | 1992-12-01 | Elan Transdermal Ltd | Preparations and compositions comprising nicotine for percutaneous administration |
US4908213A (en) * | 1989-02-21 | 1990-03-13 | Schering Corporation | Transdermal delivery of nicotine |
GB2230439A (en) * | 1989-04-20 | 1990-10-24 | Alec Stanley Walter Shaw | Nicotine lozenges |
ES2133391T3 (es) * | 1991-10-04 | 1999-09-16 | Gs Dev Ab | Particulas, metodo para preparar dichas particulas y usos de las mismas. |
WO1997013528A1 (en) * | 1995-10-12 | 1997-04-17 | Gs Development Ab | A pharmaceutical composition for administration of an active substance to or through a skin or mucosal surface |
-
1997
- 1997-09-25 SE SE9703458A patent/SE9703458D0/xx unknown
-
1998
- 1998-09-15 KR KR1020007003204A patent/KR20010024305A/ko not_active Application Discontinuation
- 1998-09-15 WO PCT/SE1998/001632 patent/WO1999015171A1/en not_active Application Discontinuation
- 1998-09-15 EP EP98945685A patent/EP1023069B1/en not_active Expired - Lifetime
- 1998-09-15 EE EEP200000154A patent/EE200000154A/xx unknown
- 1998-09-15 BR BR9815395-1A patent/BR9815395A/pt not_active IP Right Cessation
- 1998-09-15 PT PT98945685T patent/PT1023069E/pt unknown
- 1998-09-15 DK DK98945685T patent/DK1023069T3/da active
- 1998-09-15 CA CA002304042A patent/CA2304042A1/en not_active Abandoned
- 1998-09-15 DE DE69819548T patent/DE69819548T2/de not_active Expired - Fee Related
- 1998-09-15 HU HU0004802A patent/HUP0004802A3/hu unknown
- 1998-09-15 AT AT98945685T patent/ATE253362T1/de not_active IP Right Cessation
- 1998-09-15 AU AU92872/98A patent/AU733619B2/en not_active Ceased
- 1998-09-15 NZ NZ50340898A patent/NZ503408A/xx unknown
- 1998-09-15 CN CN98810645A patent/CN1123343C/zh not_active Expired - Fee Related
- 1998-09-15 RU RU2000110632/14A patent/RU2201747C2/ru not_active IP Right Cessation
- 1998-09-15 JP JP2000512540A patent/JP2001517624A/ja active Pending
- 1998-09-15 MX MXPA00002955A patent/MXPA00002955A/es not_active IP Right Cessation
- 1998-09-15 ES ES98945685T patent/ES2210817T3/es not_active Expired - Lifetime
- 1998-09-25 ZA ZA988794A patent/ZA988794B/xx unknown
-
2000
- 2000-03-24 NO NO20001540A patent/NO20001540L/no not_active Application Discontinuation
- 2000-03-24 FI FI20000692A patent/FI20000692A/fi not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1023069B1 (en) | 2003-11-05 |
FI20000692A (fi) | 2000-03-24 |
ES2210817T3 (es) | 2004-07-01 |
CN1123343C (zh) | 2003-10-08 |
KR20010024305A (ko) | 2001-03-26 |
WO1999015171A1 (en) | 1999-04-01 |
EE200000154A (et) | 2001-02-15 |
BR9815395A (pt) | 2000-11-14 |
ATE253362T1 (de) | 2003-11-15 |
CN1278174A (zh) | 2000-12-27 |
NO20001540L (no) | 2000-05-25 |
NO20001540D0 (no) | 2000-03-24 |
DK1023069T3 (da) | 2004-03-08 |
EP1023069A1 (en) | 2000-08-02 |
SE9703458D0 (sv) | 1997-09-25 |
RU2201747C2 (ru) | 2003-04-10 |
AU733619B2 (en) | 2001-05-17 |
HUP0004802A3 (en) | 2001-12-28 |
NZ503408A (en) | 2004-12-24 |
JP2001517624A (ja) | 2001-10-09 |
DE69819548D1 (de) | 2003-12-11 |
MXPA00002955A (es) | 2002-04-24 |
AU9287298A (en) | 1999-04-12 |
HUP0004802A2 (hu) | 2001-05-28 |
CA2304042A1 (en) | 1999-04-01 |
PT1023069E (pt) | 2004-02-27 |
DE69819548T2 (de) | 2004-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA988794B (en) | Nicotine compositions and methods of formulation thereof | |
BR9915095A (pt) | Composição farmacêutica ministrável em aerosol | |
MX2007000273A (es) | Composiciones de liberacion sostenida que contiene moduladores del receptor de progesterona. | |
WO2005007111A3 (en) | Tetrahydroquinoline derivatives as cannabinoid receptor modulators | |
NZ501112A (en) | Substituted pyrazoles as p38 kinase inhibitors | |
RS20070076A (en) | Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases | |
GB2316004B (en) | Novel formulations for transdermal delivery of pergolide | |
BR0110767A (pt) | Derivados de piperidina farmaceuticamente ativos, em particular como moduladores da atividade de receptor de quimiocina | |
ID30353A (id) | Obat semprot topikal | |
CA2135925A1 (en) | Use of glycerin in moderating transdermal drug delivery | |
AU1537095A (en) | Therapeutic agents containing thyroid hormones | |
BR0214806A (pt) | Composições farmacêuticos de 5,7,14-triazatetraciclo-{10.3.1.02,11.0,4,9]-hexadeca-2(1 1),3,5,7,9-penteno | |
DE60202477D1 (de) | Vorrichtung zur verabreichung einer substanz | |
RS20070077A (en) | Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflamatory diseases | |
HK1063148A1 (en) | Novel formulations for the transdermal administration of fluoxetine | |
AU7496894A (en) | Antiglucocorticoid steroids for the treatment of anxiety disorders | |
WO2000037422A3 (en) | Ion channel modulating agents | |
ATE171869T1 (de) | Film zur lokalen arzneistoffabgabe für periodontale behandlung | |
YU19399A (sh) | Lokalni anestetik za spoljnu upotrebu | |
EP1344526A4 (en) | PREVENTIVE / REMEDY AGENTS FOR INFLAMMATORY DISEASES OF THE AIRWAY | |
AU1549700A (en) | Ion channel modulating agents | |
AU4537500A (en) | Ion channel modulating agents | |
GB9827034D0 (en) | Delivery formulation | |
DK0927031T3 (da) | Farmaceutisk sammensætning indeholdende nimesulid til oral admnistration | |
Rybix | t HERPANGINA |